2020 to today · Health, Food & Regulators

Pfizer's Record: The $2.3 Billion Fraud Guilty Plea, the Nigerian Drug Trial, and the 2020 COVID Vaccine Contract

Period covered: 1992 to 2026 · 35 sources

Summary

In 2009 a Pfizer subsidiary pleaded guilty to a felony and the company paid $2.3 billion, the largest health care fraud settlement in the Justice Department's history, for selling drugs for uses the FDA had refused to approve, while, in the prosecutor's words, it was in his office settling the same conduct by a company it had just bought. In 1996 it tested an antibiotic on 200 Nigerian children during a meningitis epidemic without consent, eleven of them died, and a State Department cable later recorded that it hired investigators to dig up dirt on the Nigerian attorney general to make the case go away. In 2012 it settled bribery charges in eight countries. In 2020 the United States agreed to pay it $1.95 billion for 100 million doses of a vaccine that carried immunity from suit under a federal declaration, and when a court was asked for the trial data, the FDA proposed a schedule that would have taken more than half a century. Comirnaty brought in $36.8 billion in 2021 and $37.8 billion in 2022, and the chief executive sold $5.6 million of stock the day the results were announced.

Shiley, a company Pfizer bought, sold a heart valve that was implanted in about 86,000 people. By 1992 about 450 of the valves had fractured and nearly 300 people had died. Pfizer settled the class action in August 1992 for what it told the press would cost it between $165 million and $215 million; the settlement funds, as the court later described them, ran from a guaranteed $37.5 million patient fund to as much as $130 million for medical consultation, with $500,000 to $2 million for each fracture in the United States.

The children in Kano

In 1996, during a meningitis epidemic in northern Nigeria, Pfizer took two hundred sick children who came for treatment at a hospital in Kano, gave half of them its experimental antibiotic Trovan and half a lowered dose of an approved one, and, the children's families later alleged in federal court, did not get the consent of the children or their guardians. Eleven of the children died, five who got Trovan and six who got the comparison drug. The Second Circuit, in January 2009, held that the families had pleaded facts sufficient to state a cause of action under the Alien Tort Statute for a violation of the norm of customary international law prohibiting medical experimentation on human subjects without their consent, and sent the case back for trial; the Supreme Court declined to hear Pfizer's appeal on June 29, 2010. In July 2009 Pfizer settled with the state of Kano, specifically denying any wrongdoing, with a fund of up to $35 million for the children, $30 million for health projects, and $10 million for the state's legal costs.

A State Department cable from the embassy in Abuja dated April 20, 2009 and published by WikiLeaks in December 2010 records what Pfizer's country manager told American diplomats about how the federal case was handled: that Pfizer had hired investigators to uncover corruption links to Federal Attorney General Michael Aondoakaa to expose him and put pressure on him to drop the federal cases, that Pfizer's investigators were passing this information to local media, and that the attorney general's cronies were pressuring him to drop the suit for fear of further negative articles. Pfizer told the Guardian that the statements purportedly contained in such documents are completely false.

The plea

On September 2, 2009 the Justice Department announced the largest health care fraud settlement in its history. Pfizer's subsidiary Pharmacia and Upjohn pleaded guilty to a felony under the Food, Drug and Cosmetic Act for misbranding Bextra with the intent to defraud or mislead; Pfizer had promoted the painkiller for uses and doses the FDA specifically declined to approve due to safety concerns. The criminal fine was $1.195 billion, the largest criminal fine ever imposed in the United States for any matter, plus $105 million forfeited. The company paid another $1 billion to settle civil claims that it had illegally promoted Bextra, the antipsychotic Geodon, the antibiotic Zyvox, and the epilepsy drug Lyrica. Six whistleblowers shared more than $102 million.

It was not the first time. In May 2004 Warner-Lambert, which Pfizer had bought in 2000, pleaded guilty and paid $430 million over the promotion of Neurontin for unapproved uses. In April 2007 Pharmacia subsidiaries paid $34.7 million over the growth hormone Genotropin. The acting United States attorney in Boston, Mike Loucks, said in 2009: at the very same time Pfizer was in our office negotiating and resolving the allegations of criminal conduct by its then newly acquired subsidiary, Warner-Lambert, Pfizer was itself in its other operations violating those very same laws.

The bribes

On August 7, 2012 the Securities and Exchange Commission charged Pfizer with violating the Foreign Corrupt Practices Act; its subsidiaries in Bulgaria, China, Croatia, the Czech Republic, Italy, Kazakhstan, Russia, and Serbia had made improper payments to foreign officials to obtain regulatory and formulary approvals, sales, and increased prescriptions. The head of the SEC's unit said the bribery was so entwined in their sales culture that they offered points and bonus programs to improperly reward foreign officials who proved to be their best customers. A Pfizer subsidiary admitted paying more than $2 million in bribes between 1997 and 2006 and making more than $7 million in profit from them, and paid a $15 million penalty under a deferred prosecution agreement; with the SEC settlements the total was about $60 million.

The contract

On July 22, 2020 the Department of Health and Human Services and the Department of Defense announced that the government would pay Pfizer $1.95 billion for the first 100 million doses of its COVID-19 vaccine once it was authorized, with an option on 500 million more, and on December 23 it bought 100 million more for the same price. Pfizer took no federal money for development, and its chief executive, Albert Bourla, explained why on September 13, 2020: When you get money from someone that always comes with strings. They want to see how we are going to progress, what type of moves you are going to do. They want reports. I didn't want to have any of that. And also, I wanted to keep Pfizer out of politics, by the way. Its partner BioNTech took up to 375 million euros from the German government that same month, and had taken $55 million from the Gates Foundation the year before.

The government had already made sure the company could not be sued. On March 10, 2020 the Secretary of Health and Human Services signed a declaration under the Public Readiness and Emergency Preparedness Act, effective February 4, that gave manufacturers, distributors, and program planners immunity from any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures, except for willful misconduct. The Secretary's own reading was that the Act precludes, for example, liability claims alleging negligence by a manufacturer in creating a vaccine. What is left is a federal compensation program. Its own figures as of August 1, 2026: 14,169 claims filed over COVID-19 countermeasures, 11,104 of them over the vaccines; 7,790 decided; 112 found eligible; 62 paid; 7,678 denied, 3,209 of them for not submitting medical records and 2,674 for missing the filing deadline.

The results and the stock

On November 18, 2020 Pfizer announced that its trial had met its endpoints with a vaccine efficacy rate of 95 percent, based on 170 cases of COVID-19, 162 in the placebo group and 8 in the vaccine group. On December 11 the FDA issued the first emergency use authorization for a COVID-19 vaccine, for people 16 and older, citing the same 170 cases and safety data on 37,586 participants with a median of two months of follow-up after the second dose. On August 23, 2021 the FDA licensed it as Comirnaty, and the same announcement said the data demonstrate increased risks of myocarditis and pericarditis, particularly within the seven days following the second dose, with the observed risk highest in males 12 through 17 years of age.

On November 9, 2020, the day Pfizer first announced that the vaccine worked, Bourla sold 132,508 shares at $41.94, $5.56 million, under a trading plan he had adopted on August 19, 2020, according to the Form 4 he filed with the SEC the next day. Comirnaty brought the company $36.8 billion in 2021 and $37.8 billion in 2022, and Paxlovid another $18.9 billion in 2022, in a year when Pfizer's total revenue was $100.3 billion, an all-time high for Pfizer in its own words.

The data

In 2021 a group of doctors and scientists asked the FDA under the Freedom of Information Act for the documents it had relied on to license the vaccine. The FDA told the court there were more than 329,000 pages and proposed to release 500 pages a month, a schedule the plaintiffs calculated at 54 years and 10 months, and at about 75 years once the FDA found more records. On January 6, 2022 Judge Mark Pittman in Fort Worth wrote that there may not be a more important issue at the Food and Drug Administration than the pandemic, the Pfizer vaccine, getting every American vaccinated, and making sure that the American public is assured that this was not rushed on behalf of the United States, found the request to be of paramount public importance, and ordered 55,000 pages a month.

The label

On June 25, 2021 the FDA added a warning to the Pfizer and Moderna fact sheets that reports of adverse events suggest increased risks of myocarditis and pericarditis, particularly following the second dose. The CDC's data at the time put the reporting rate after a second dose at 62.8 cases per million for males 12 to 17 and 50.5 per million for males 18 to 24, with 96 percent of the confirmed cases hospitalized, and its advisory committee concluded the benefits clearly outweigh the risks in all populations. On June 25, 2025 the FDA approved a required update to the Comirnaty and Spikevax labels putting the incidence at about 8 cases per million doses overall and about 27 per million in males 12 to 24 for the 2023 to 2024 formula, and noting a follow-up study in which some patients still had abnormal cardiac MRI findings whose clinical and prognostic significance is not known.

The contracts abroad

Public Citizen obtained nine of Pfizer's vaccine contracts and published them in October 2021. Brazil expressly and irrevocably waives any right of immunity which either it or its assets may have, was prohibited from making any public announcement concerning the existence, subject matter or terms of the agreement, and could not accept donated Pfizer doses from other countries without Pfizer's permission; Colombia, Peru, and the Dominican Republic waived immunity against precautionary seizure of any of its assets; disputes went to private arbitration in New York. The Bureau of Investigative Journalism reported in February 2021 that in Argentina and Brazil, Pfizer asked for sovereign assets to be put up as collateral for any future legal costs, which might include federal bank reserves, embassy buildings or military bases. Argentina's health minister said Pfizer misbehaved with Argentina. Its intolerance with us was tremendous.

The states, and Congress

Texas sued Pfizer on November 30, 2023 under its consumer protection law over the 95 percent claim and over what it called efforts to silence critics. A federal judge in Lubbock dismissed the case on December 30, 2024, finding that the Defendant is entitled to immunity under the Public Readiness and Emergency Act, that federal law preempts the claims, and that the company's statements were not connected to any trade or commerce; Texas appealed, and the Fifth Circuit heard argument at the start of September 2026. Kansas sued in June 2024; Pfizer moved the case to federal court and a federal judge sent it back to state court in May 2025, where it is pending.

Pfizer's own lobbying disclosures put its federal lobbying at $10.9 million in 2020, $10.3 million in 2021, $11.4 million in 2022, $14.1 million in 2023, $8.9 million in 2024, and $12.6 million in 2025, not counting the outside firms it pays. Its political action committee gave $2.0 million to federal candidates in the 2020 cycle, $1.6 million in 2022, and $1.4 million in 2024. In January 2025 the company paid $59.7 million to settle claims that a subsidiary it had bought paid doctors to prescribe a migraine drug, without admitting liability.

← 2020 to today

Primary Sources (35)

Documents, court filings, official reports, and broadcasts cited in this report.

United States Senate, Office of Public Records. Pfizer's own quarterly LD-2 reports, summed: $10.87 million 2020, $10.25 million 2021, $11.42 million 2022, $14.13 million 2023, $8.86 million 2024, $12.63 million 2025, excluding outside firms.
Federal Election Commission. Contributions to federal candidate committees: $2,040,086 in 2019 to 2020; $1,590,000 in 2021 to 2022; $1,411,480 in 2023 to 2024.
1996
United States District Court for the Southern District of Ohio (Justia). The 1992 Shiley heart valve settlement: a guaranteed $37.5 million patient fund, up to $130 million for consultation, $500,000 to $2 million per fracture; about 450 fractures and about 300 deaths by 1992.
2004
U.S. Department of Justice. Guilty plea; $240 million criminal fine; Neurontin; Pfizer, the owner since June 2000, to institute a compliance program.
2009
United States Court of Appeals for the Second Circuit (CourtListener). Two hundred sick children at the Kano hospital in 1996; eleven deaths; no informed consent alleged; the norm of customary international law prohibiting medical experimentation on human subjects without their consent; reversed and remanded.
2009
Pfizer Inc.. Pfizer specifically denies any wrongdoing; a fund of up to $35 million; $30 million in health initiatives; $10 million in legal costs.
2009
U.S. Department of Justice. $2.3 billion; Pharmacia & Upjohn's felony plea for misbranding Bextra with the intent to defraud or mislead; the $1.195 billion criminal fine, the largest ever imposed in the United States for any matter; $1 billion civil; Bextra, Geodon, Zyvox, Lyrica; Loucks on Warner-Lambert.
2010
Supreme Court of the United States. The petition for a writ of certiorari is denied.
2010
The Guardian. The Abuja cable of April 20, 2009: Pfizer had hired investigators to uncover corruption links to the federal attorney general to expose him and put pressure on him to drop the federal cases; Pfizer's denial.
2012
U.S. Department of Justice. More than $2 million in bribes between 1997 and 2006; more than $7 million in profits; deferred prosecution agreement.
2012
U.S. Securities and Exchange Commission. Subsidiaries in Bulgaria, China, Croatia, the Czech Republic, Italy, Kazakhstan, Russia, and Serbia; bribery so entwined in their sales culture that they offered points and bonus programs; more than $45 million from Pfizer and Wyeth.
2020
Federal Register (85 FR 15198). Signed March 10, 2020, effective February 4, 2020; immunity for manufacturers, distributors, program planners, and qualified persons from any claim of loss except willful misconduct; the Act precludes liability claims alleging negligence by a manufacturer in creating a vaccine.
2020
Pfizer Inc.. $1.95 billion upon receipt of the first 100 million doses.
2020
U.S. Department of Health and Human Services and Department of Defense. $1.95 billion for the first 100 million doses after authorization or licensure; up to 500 million more; without U.S. government financial support for development.
2020
CBS News. When you get money from someone that always comes with strings; I wanted to keep Pfizer out of politics.
2020
BioNTech SE. A grant of up to 375 million euros for accelerated development of SARS-CoV-2 vaccines.
2020
U.S. Securities and Exchange Commission (EDGAR). Sale of 132,508 shares at $41.94 under a Rule 10b5-1 plan adopted August 19, 2020; 78,273 shares owned after.
2020
Pfizer Inc.. A vaccine efficacy rate of 95 percent based on 170 cases, 162 placebo and 8 vaccine.
2020
U.S. Food and Drug Administration (GovDelivery copy). 95 percent effective with eight cases in the vaccine group and 162 in the placebo group; 37,586 participants followed a median of two months after the second dose; not an FDA approval.
2020
Pfizer Inc.. Another $1.95 billion for 100 million doses; option for up to 400 million more.
2021
The Bureau of Investigative Journalism. In Argentina and Brazil, Pfizer asked for sovereign assets to be put up as collateral; federal bank reserves, embassy buildings or military bases; Pfizer misbehaved with Argentina.
2021
Indian Health Service (reproducing the FDA statement of June 25, 2021). Reports of adverse events suggest increased risks of myocarditis and pericarditis, particularly following the second dose.
2021
Centers for Disease Control and Prevention. 62.8 and 50.5 reported cases per million second doses among males 12 to 17 and 18 to 24; 96 percent hospitalized; benefits clearly outweigh the risks in all populations.
2021
U.S. Food and Drug Administration. Comirnaty for 16 and older; 91 percent effective in the trial; increased risks of myocarditis and pericarditis, highest in males 12 through 17.
2021
Public Citizen. Nine contracts; Brazil expressly and irrevocably waives any right of immunity; secrecy clauses; no donations without Pfizer's permission; private arbitration; seizure of state assets.
2021
United States District Court for the Northern District of Texas (RECAP archive). More than 329,000 pages potentially responsive; FDA proposes 500 pages per month; the plaintiffs' arithmetic of 54 years and 10 months in ECF 24.
2022
United States District Court for the Northern District of Texas (RECAP archive). Judge Pittman: this FOIA request is of paramount public importance; the remaining documents at a rate of 55,000 pages every 30 days.
2022
Pfizer Inc.. Full-year revenues of $81.3 billion; Comirnaty $36,781 million.
2023
Pfizer Inc.. Full-year revenues of $100.3 billion, an all-time high for Pfizer; Comirnaty $37,806 million; Paxlovid $18,933 million.
2023
Office of the Attorney General of Texas. The 95 percent claim; durability and transmission; efforts to silence critics; filed in Lubbock County.
2024
United States District Court for the Northern District of Texas (RECAP archive). Judge Cummings: immunity under the PREP Act; preemption under the PREP Act and the FDCA; the statements not connected to any trade or commerce.
2025
U.S. Department of Justice. $59,746,277; Biohaven speaker programs March 2020 to September 2022; allegations only, no determination of liability.
2025
United States District Court for the District of Kansas (Justia). Judge Crabtree rejects federal-officer removal and PREP Act complete preemption and remands to the Kansas state court where filed.
2025
U.S. Food and Drug Administration. About 8 cases per million doses overall and about 27 per million in males 12 to 24 for the 2023 to 2024 formula; persistent abnormal cardiac MRI findings whose significance is not known.
2026
Health Resources and Services Administration. 14,169 COVID-19 countermeasure claims, 11,104 over the vaccines; 7,790 decided; 112 eligible; 62 compensated; 7,678 denied, 3,209 for missing medical records and 2,674 for the filing deadline.

Documented Records (1)

Chronological entries extracted from the primary sources above.

2020
September 2, 2009 to December 30, 2024
The company that holds the record for the largest criminal fine in American history, $1.195 billion in 2009 for selling drugs for uses the FDA had refused, and that settled bribery charges in eight countries and a consent case over the deaths of Nigerian children, was paid $3.9 billion for 200 million vaccine doses in 2020 under a federal declaration that shields it from any suit but willful misconduct. The FDA proposed to release the trial data at 500 pages a month; a judge ordered 55,000. A state's suit over the 95 percent claim was dismissed on the immunity. Comirnaty brought $74.6 billion in 2021 and 2022.
“Pfizer promoted the sale of Bextra for several uses and dosages that the FDA specifically declined to approve due to safety concerns.”
Pfizer Inc.; the Department of Health and Human Services; the Food and Drug Administration. Violates: The right to sue for an injury, removed in advance by declaration. The right to see the data, delayed by proposal.. Source: Justice Department Announces Largest Health Care Fraud Settlement in Its History, U.S. Department of Justice

Timeline Events (7)

Dated events from this investigation in the site timeline.

June 25, 2025
FDA requires an expanded myocarditis warning on the mRNA vaccines
About 27 cases per million doses in males 12 to 24.
January 6, 2022
Judge orders the FDA to release Pfizer's data at 55,000 pages a month, not 500
A request of paramount public importance.
November 9, 2020
Pfizer's chief executive sells $5.6 million of stock the day the results are announced
Under a plan adopted August 19, 2020.
July 22, 2020
$1.95 billion to Pfizer for 100 million doses of an unauthorized vaccine
A second $1.95 billion on December 23.
March 10, 2020
PREP Act declaration: vaccine makers immune from suit except for willful misconduct
Signed before there was a vaccine.
August 7, 2012
Pfizer settles bribery charges in eight countries for about $60 million
Points and bonus programs for foreign officials.
September 2, 2009
Pfizer pays $2.3 billion; a subsidiary pleads guilty; the largest criminal fine in U.S. history
For selling Bextra for uses the FDA had refused.
Pfizer's Record: The $2.3 Billion Fraud Guilty Plea, the Nigerian Drug Trial, and the 2020 COVID Vaccine Contract | Spirit of '76